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Interstrand cross-links (ICLs) make up a unique class of DNA lesions in which both strands of the double
helix are covalently joined, precluding strand opening during replication and transcription. The repair of DNA
ICLs has become a focus of study since ICLs are recognized as the main cytotoxic lesion inflicted by an array
of alkylating compounds used in cancer treatment. As is the case for double-strand breaks, a damage-free
homologous copy is essential for the removal of ICLs in an error-free manner. However, recombination-
independent mechanisms may exist to remove ICLs in an error-prone fashion. We have developed an in vivo
reactivation assay that can be used to examine the removal of site-specific mitomycin C-mediated ICLs in
mammalian cells. We found that the removal of the ICL from the reporter substrate could take place in the
absence of undamaged homologous sequences in repair-proficient cells, suggesting a cross-link repair mech-
anism that is independent of homologous recombination. Systematic analysis of nucleotide excision repair
mutants demonstrated the involvement of transcription-coupled nucleotide excision repair and a partial
requirement for the lesion bypass DNA polymerase  encoded by the human POLH gene. From these
observations, we propose the existence of a recombination-independent and mutagenic repair pathway for the
removal of ICLs in mammalian cells.
A DNA interstrand cross-link (ICL) is formed when both
strands of the double helix are covalently joined by a single
molecule. Since ICLs effectively prevent strand separation, es-
sential metabolic functions of DNA such as transcription, rep-
lication, and recombination are severely blocked by these le-
sions. The formation of DNA ICLs appears to be an essential
prerequisite for the potent cytotoxicity and antitumor activity
of a large array of chemotherapeutic compounds used in can-
cer treatment (41).
In Escherichia coli and lower eukaryotes, the repair of ICLs
is carried out primarily by a combination of the nucleotide
excision repair (NER) and homologous recombination path-
ways. In a model proposed by Cole et al. (9, 10) based on
genetic evidence, the NER mechanism introduces incisions
flanking the site of the cross-link on the same strand. The
resulting gap is then repaired by using a lesion-free homolo-
gous chromosome as a donor via the recA-dependent homol-
ogous recombination pathway. Subsequent biochemical analy-
ses fully confirmed that the removal of ICLs in E. coli is
mediated by both NER and homologous recombination (39,
44, 45). Similarly, with Saccharomyces cerevisiae, a group of
RAD3 mutants (deficient in NER) and a group of RAD52
mutants (deficient in homologous recombination) are hyper-
sensitive to the killing of bifunctional alkylating agents, sug-
gesting that both pathways are essential for the repair of ICLs
(21, 28, 30, 38). These observations also indicated the presence
of a combination of NER and homologous-recombination
mechanisms in ICL repair. More recently, direct evidence of
psoralen ICL-induced homologous recombination in budding
yeast has been demonstrated (16). While the combined NER–
homologous-recombination mechanism appears to be the pre-
dominant error-free pathway for ICL repair in E. coli and
yeast, homology-independent ICL repair has also been ob-
served in both organisms. In E. coli, a moderate level of ICL
repair takes place in recombination-deficient backgrounds and
is likely mediated by a lesion bypass process in which the
gapped intermediate created by the Uvr(A)BC excinuclease is
resynthesized by DNA polymerase II (polB) (4, 5) indepen-
dently of undamaged homologous sequences. In S. cerevisiae,
the pso1 mutant exhibits profound sensitivity to psoralen cross-
links. Identification of the gene responsible for such sensitivity
revealed that the pso1/rev3 locus encodes the catalytic subunit
of polymerase , a lesion bypass DNA polymerase (7, 31, 34).
A possible role for polymerase  may be the resynthesis of the
gap after the initial uncoupling of the cross-link. Consistent
with this notion, the pso1 mutant was found to be defective in
ICL processing in stationary-phase yeast cells (28). More re-
cently, mutagenic repair of DNA ICLs was also detected in
repair-proficient yeast cells (16).
Several mammalian mutants defective in homologous re-
combination are highly sensitive to bifunctional alkylating
agents, which indicates an essential role for recombination in
the repair of ICLs in higher eukaryotes (22, 32, 36). In contrast,
most mammalian NER mutant cell lines display only moderate
sensitivity to the cross-linking agents, suggesting that the NER
mechanism may have a limited participation in the removal of
DNA ICLs (3, 19). However, since ERCC1 and ERCC4/XPF
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mutants exhibit profound hypersensitivity to cross-linking
agents, it has been suggested that the endonuclease activity of
ERCC1-XPF may provide unhooking activity at ICL-stalled
replication forks (25). These findings also imply that a pathway
other than NER may recognize and process ICLs into recom-
binogenic substrates. The observation that nitrogen mustard
treatment generates double-strand breaks (DSBs) in mamma-
lian cells provides a connection between ICL repair and ho-
mologous recombination (12). Interestingly, a recent study of
ICL repair as a function of the cell cycle showed that the
introduction of psoralen ICLs during late S or G2 phase of the
cell cycle did not activate the G2-M checkpoint, suggesting that
mammalian cells are able to tolerate the presence of unre-
paired ICLs until they are encountered by the DNA replication
machinery (2). This suggests that ICLs can be converted into
replication-induced DSBs that are subject to homologous re-
combination. As is the case with E. coli and yeast, an error-
prone repair pathway exists in mammalian cells and appears to
be dependent on NER and a lesion bypass mechanism (47).
These findings may explain the observation that bifunctional
alkylating agents are more mutagenic than their monofunc-
tional derivatives (50).
As a model lesion, photoreactive psoralen derivatives have
been used in most studies of ICL repair. The formation of
psoralen-induced ICLs leads to drastic distortion of the double
helix (13), which may be detected by a variety of damage
recognition complexes that sense the integrity of the helical
structure. Conversely, ICLs induced by mitomycin C (MMC)
result in minimum disruption of the helix structure and also
have a distinct sequence preference (35, 48). In a previous
study, psoralen-induced ICLs were used to demonstrate the
recombination-independent repair (RIR) of cross-links in a
reporter-based reactivation assay (47). Here, we present data
showing that repair of ICLs formed with MMC is similar to
that of the psoralen ICLs, which involves a lesion bypass pro-
cess. We also present evidence that transcription-coupled re-
pair (TCR) plays an important role in the removal of ICLs
located in the actively transcribed region. These results further
substantiate a model of combined NER and lesion bypass
mechanisms for error-prone ICL removal.
MATERIALS AND METHODS
Preparation of MMC ICLs and lesion-defined luciferase reporter substrates.
Two complementary oligonucleotides with the following sequences were synthe-
sized and annealed: 5-TAGATATCATCGATATAGT and 5-TAGACTATAT
CGATGATAT. Bold letters indicate the guanine residues involved in the MMC
cross-link, and a BspDI recognition sequence in the oligonucleotides is under-
lined. Annealing of these oligonucleotides created identical 3-nucleotide 5 co-
hesive ends at both ends of the duplex. The annealed duplex oligonucleotides
were incubated with MMC in a sodium dithionite-catalyzed reaction as previ-
ously described (48). The ICL DNA was purified in a single step by high-
temperature Sephadex chromatography and characterized by a combined P1
nuclease-T4 kinase assay and by denaturing polyacrylamide gel electrophoresis
(PAGE) to ensure that the purity of the cross-linking percentage was at least
97% (49). To insert the cross-linked oligonucleotide, pCMV-LUC was digested
by NheI and filled in with a single dCMP residue. The latter step prevents
self-ligation of the plasmid by creating ends that can only be ligated to the
cross-linked oligonucleotide. After ligation of the cross-linked oligonucleotide to
the vector, covalently closed cross-linked plasmid was purified by CsCl-ethidium
bromide gradient centrifugation. For the construction of the undamaged lucif-
erase control plasmid, an unmodified oligonucleotide was cloned into the NheI
site of the pCMV-LUC plasmid as described for the cross-linked oligonucleotide.
The purity of each cross-linked plasmid was determined by the release of a
FIG. 1. Preparation of an MMC-cross-linked plasmid substrate. (A) Preannealed oligonucleotides with a single central CpG sequence were
incubated with activated MMC, and cross-linked oligonucleotides were purified by high-temperature size exclusion column chromatography. A
purified cross-linked oligonucleotide (lane 1) and an unmodified oligonucleotide (lane 2) were resolved by denaturing 20% PAGE. (B). Purity of
the site-specific MMC-cross-linked plasmid substrate. Results for pCMV-LUC plasmid with an MMC-cross-linked oligonucleotide inserted at the
NheI site (lane 1), pCMV-LUC with an unmodified oligonucleotide inserted at the NheI site (lane 2), and pCMV-LUC vector only (lane 3) are
shown. All three sample DNAs were digested with ScaI and HindIII to release a 105-bp fragment (86 bp in the case of vector only) and resolved
by denaturing 15% PAGE. End labeling was used to visualize the DNA by autoradiography.
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cross-link-containing fragment by restriction enzyme digestion and examination
of the fragment with denaturing PAGE (see Fig. 1).
Expression of the XPV/POLH gene. Full-length POLH cDNA was released as
a 2.6-kb BamHI-SalI fragment from the pECUh6-XPV plasmid (51) (kindly
provided by Zhigang Wang, University of Kentucky) and cloned in frame into the
pcDNA4.0HisMaxC vector (Invitrogen). Polymerase  (PolH) expressed from
the resulting construct carried the Xpress tag (DLYDDDDK) at the N terminus.
The expression of PolH was verified by immunoblotting with a monoclonal
antibody against the Xpress tag (Invitrogen).
Cell lines and tissue culture conditions. Mammalian cell lines used in this
study were purchased from either the American Type Culture Collection (Ma-
nassas, Va.) or the Human Genetics Mutant Cell Repository (Camden, N.J.)
unless otherwise stated. Xeroderma pigmentosum (XP) fibroblast cell lines
XP2OS (XPA), XP4PA (XPC), XP6BE (XPD), and XP30RO (XPV) and Cock-
ayne syndrome (CS) fibroblast cell line CS3BE (CSA) were maintained in min-
imal essential medium (MEM) supplemented with 15% fetal calf serum (FCS).
The human repair-proficient cell lines HT-1080 (fibrosarcoma) and RKO (colon
cancer epithelial) and the Chinese hamster lung fibroblast cell line V79 were
cultured in MEM supplemented with 10% FCS. The CHO AA8 cell line and its
derived mutants UV24 (XPB), UV61 (ERCC6/CSB), UV24 (XPB), UV41 (XPF),
and UV135 (XPG) were grown in Dulbecco MEM supplemented with 10% FCS.
The E1KO7-5 (ERCC1KO) and E1KO-47 (ERCC1OK) CHO lines were main-
tained under similar conditions. The irs1 (XRCC2) and irs1SF (XRCC3) mutants
were maintained in MEM supplemented with 10% FCS.
Repair reactivation assay. In order to introduce the cross-linked reporter
substrates into cultured cells, transient transfections were performed with the
FuGENE-6 reagent (Roche Molecular Biochemicals) according to the recom-
mendations of the manufacturer. When needed, carrier DNA was used to equal-
ize the total amount of plasmid DNA. For the luciferase reactivation assay, 0.1
to 2.5 ng of cross-linked or unmodified control substrate was used for transfec-
tions of 1.5  105 cells seeded in 35-mm-diameter plates. Cells were harvested
for the preparation of protein extracts 30 h after transfection. In the experiments
where TCR mutants were examined, cells were harvested 18 h after transfection.
The luciferase activity was determined by using the Luciferase Assay System
(Promega) and measured on a Moonlight 3010 luminometer (Pharmingen). The
linear ranges of the luciferase assay, both in terms of the amount of transfected
DNA and the amount of protein extract used in the luciferase assay, were
established individually for each cell line. Each transfection was performed at
least three times, and the standard deviation is provided for each data point.
Mutation analysis. MMC cross-linked plasmid (150 ng) was transfected into 5
 105 cells/60-mm-diameter plate and harvested 30 h after transfection. Plasmid
DNA was recovered by a modified alkaline lysis procedure (14) and subsequently
electroporated into the E. coli AB2480 (uvrA recA) mutant (17), which is defec-
tive in both NER and homologous recombination. The resulting colonies were
lysed and directly amplified by PCR to generate a 255-bp fragment flanking the
cross-linked region. The PCR products were digested with BspDI to identify
colonies containing plasmid that was resistant to BspDI cleavage. Plasmids that
were found resistant to BspDI cleavage were further analyzed by DNA sequenc-
ing.
RESULTS
Generation of site-specific MMC cross-linked DNA sub-
strates. The nucleotide target for MMC ICL formation has
been determined to be a 5 CpG 3 sequence (42, 48). We have
designed an oligonucleotide that has only one CpG motif in
the duplex region. The duplex oligonucleotide was subjected to
an MMC cross-linking reaction, and the cross-linked products
were purified by high-temperature gel filtration. Analysis of the
purified oligonucleotide by denaturing PAGE indicated that
there were no detectable levels of un-cross-linked oligonucle-
otide (Fig. 1A).
Repair of MMC ICL in NER-proficient cells. We prepared
plasmid substrate containing a site-specific MMC cross-link by
using in vitro ligation to insert the cross-linked oligonucleotide
into the plasmid vector as described previously (26). The MMC
cross-link was positioned between the CAP (transcription ini-
tiation) site of a cytomegalovirus promoter and the translation
initiation site of the downstream firefly luciferase reporter
gene. As shown (Fig. 1B), the purified cross-linked plasmid
substrate contained no detectable amount of un-cross-linked
plasmid or empty vector. As a result of the presence of the
MMC ICLs, the transcription of the luciferase reporter gene
becomes dependent upon the removal of the cross-links. To
quantify the level of ICL repair, we constructed an identical
reporter plasmid without cross-links. The efficiency of the ICL
repair was determined by normalizing luciferase activities from
cells transfected with cross-linked plasmid against those of
cells transfected with an unmodified plasmid. Initially, two
human repair-proficient cell lines (HT-1080 and RKO) were
examined, and the reactivation of luciferase activity in these
cell lines was found to range between 40 and 60% of that
observed with unmodified plasmid (Fig. 2). These results sug-
gest that a substantial portion of the MMC ICLs in the re-
porter plasmid were removed to allow the expression of the
luciferase gene. Also, the repair of the cross-links apparently
took place in the absence of undamaged homologous se-
quences, since there is no genomic sequence exhibiting signif-
icant homology to the pCMV-LUC plasmid according to the
results of a BLAST search of the complete human sequence
from the Celera database. Moreover, a sequence alignment
analysis of the pCMV-LUC vector showed no tandem repeats
flanking the cross-linked region to support a single-strand an-
nealing type of intramolecular recombination that could lead
to the reactivation of luciferase expression. To examine this
RIR of ICLs in other repair-proficient cells, we tested two
normal hamster cell lines, AA8 and V79. Both cell lines gen-
erated levels of reactivation similar to those of the human
repair-proficient cells (Fig. 2).
NER is essential for the RIR of MMC ICLs. The NER
pathway is the principal pathway for the repair of bulky DNA
adducts. Two NER mutants, ERCC1 and XPF mutants, are
hypersensitive to bifunctional alkylating agents, while other
NER mutants exhibit moderate sensitivity (3, 19). To investi-
gate whether the RIR of ICLs described above requires NER
components, we used the MMC-cross-linked luciferase re-
porter to assay a panel of representative human NER mutants.
As shown (Fig. 3A), the XPA mutant, XP2OS, was extremely
deficient in reactivating the luciferase reporter. Upon reintro-
FIG. 2. Reactivation of the luciferase reporter gene by repair of a
single site-specific MMC ICL in the NER-proficient cell lines HT-
1080, RKO, AA8, and V79. The relative efficiencies of ICL repair were
calculated as the percentage of luciferase activity of the cross-linked
reporter normalized to that of the unmodified reporter.
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duction of a full-length XPA cDNA expression vector via co-
transfection (C-XPA), the repair reactivation was restored to
near the normal level. This result indicates that the function of
XPA as a DNA damage-binding protein (24) and the incision
complex assembly scaffold (46) are required in the RIR of
MMC ICLs. The XPG and XPF mutants, which are defective in
the 3 and 5 excinuclease activities of NER, respectively, were
also defective in reactivating the luciferase gene (Fig. 3A),
indicating that both incision nucleases are required in the RIR
of ICLs. Additionally, ICL repair was also greatly reduced in
the XPC and XPD mutants, indicating that the DNA damage
recognition activity of XPC (40) and the helicase activity of
XPD are important for the RIR of ICLs in human cells.
Confirmatory results were obtained upon a similar examina-
tion of a series of Chinese hamster mutants that harbor defec-
tive NER genes. ERCC1KO is an ERCC1-null cell line gener-
ated via a targeted knockout in repair-proficient CHO-ATS49
cells, and ERCC1OK is a stable transformant of ERCC1KO
obtained upon integration of a wild-type ERCC1 cDNA ex-
pression vector, resulting in full complementation of both UV-
and MMC-sensitive phenotypes (1, 47). The reactivation assay
results showed (Fig. 3B) that ERCC1KO cells were severely
defective in the RIR of MMC ICLs but that complemented
ERCC1 cells exhibited a level of ICL repair comparable to that
of the repair-proficient cells. An analysis of additional hamster
NER mutants confirmed that the 5 incision activity of the
ERCC1-XPF complex, the helicase activity of the TFIIH com-
plex (ERCC2 and ERCC3), and the 3 incision activity
(ERCC5) are involved in the RIR of MMC ICLs in mamma-
lian cells. Taken together, these results indicate that an intact
NER pathway is necessary for the removal of MMC ICLs in
the absence of undamaged homologous sequences.
Lesion bypass PolH plays a role in the repair of MMC ICLs.
In yeast, loss of the translesion polymerase  leads to severe
sensitivity to cross-linking agents (31, 34). In mammals, XPV
mutant cells exhibited a high mutation frequency and altered
mutation spectrum when triplex-forming oligonucleotide-di-
rected psoralen adducts were introduced (37). In light of these
observations, we tested an XP-variant mutant cell line,
XP30RO, which is defective in the human lesion bypass PolH
(23, 27). The result (Fig. 4A) showed a drastic reduction in the
reactivation of the luciferase reporter, suggesting an important
role for the POLH gene product in the RIR of MMC ICLs.
To verify whether the defective ICL repair in XPV cells was
indeed caused by the loss of the PolH function, we constructed
a cDNA expression vector, which produces full-length PolH in
transient-transfection studies (Fig. 4B). When this construct
was cotransfected with the cross-linked luciferase substrate,
the repair ability of the XP30RO mutant was fully restored
(Fig. 4A). This result provided additional support for the idea
that PolH has a role in the RIR of ICLs, presumably during a
lesion bypass step.
Lack of XRCC2 and XRCC3 functions does not affect RIR of
ICLs. The pivotal role of recombinational ICL repair mecha-
nisms is reflected by the extreme hypersensitivity of the irs1
and irs1SF mutants to cross-linking agents (6). The mechanis-
FIG. 3. NER mutants are defective in repair of the cross-linked
luciferase reporter. (A) Repair efficiency of XP mutants compared to
that of repair-proficient HT-1080 cells. C-XPA, complemented XPA;
C-XPC, complemented XPC. (B) Repair efficiency of hamster NER-
deficient mutant cells compared to that of parental AA8 and V79 cells.
FIG. 4. Participation of PolH in the RIR of MMC ICLs. (A). The
ectopic expression of POLH in XP30RO complemented its ICL repair
defect. C-XPV, complemented XPV. (B) Immunoblot of tagged PolH
with a monoclonal antibody against the Xpress tag. Results demon-
strate the expression of exogenous PolH in 293T cells (lane 1) and in
XP30RO cells (lane 2) compared to that in XP30RO cells transfected
with control vector only.
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tic basis for the cross-link hypersensitivity has been identified
as a defect in gene conversion (22, 36). We tested both the irs1
and the irs1SF mutant to see whether the loss of recombina-
tional ICL repair function influences reactivation in our assay
system. Our results (Fig. 3B) showed that the repair of the
MMC ICLs was normal in both the irs1 and the irs1SF mutant
compared to that in their isogenic parental cell lines V79 and
AA8, respectively. These observations provide additional evi-
dence that the repair of MMC ICLs occurs in the absence of
homologous recombination.
Involvement of transcription-coupled NER in the RIR of
MMC ICLs. The site-specific MMC ICL was placed in an
actively transcribed region in the luciferase reporter plasmid.
Therefore, TCR may play a role in the recombination-inde-
pendent removal of cross-links. We tested two cell lines,
CS3BE and UV61, that are deficient in the TCR genes CSA
and CSB, respectively. Based on the kinetics of TCR, the cells
were harvested 18 h after transfection for the luciferase assay
instead of 30 h after transfection as in the experiment de-
scribed above. By shortening the incubation time, the involve-
ment of TCR, if any, would not be masked by the global repair
pathway, as may occur when longer incubation times are al-
lowed. As shown (Fig. 5), both mutants have substantially
reduced levels of ICL repair compared to that of repair-pro-
ficient cells, albeit the reduction is not to the same extent as
that in XPA and ERCC1 mutants. Complementing the CS3BE
mutant with wild-type CSA cDNA through transient transfec-
tion resulted in the substantial restoration of ICL repair. Sim-
ilar results were obtained when the above-mentioned cell lines
were tested with psoralen-cross-linked luciferase reporter plas-
mid (data not shown). These results, taken together, suggest
that the TCR pathway plays a significant role in the repair of
the MMC ICLs in the cross-linked luciferase reporter sub-
strate.
Mutagenic effect of the RIR pathway. In the absence of a
lesion-free homologous donor, the recombination-indepen-
dent removal of MMC ICLs may lead to mutations at the site
of the cross-links. To determine whether mutations are gener-
ated as a result of the RIR of ICLs, MMC cross-linked lucif-
erase reporter substrates were transfected into the HT1080 or
AA8 cell line and incubated for 30 h to allow the cross-links to
be repaired in vivo. Subsequently, plasmid DNA was recovered
and transformed into the E. coli AB2480 (recA uvrA) strain.
Because the AB2480 strain is deficient in both NER and ho-
mologous recombination (17), only lesion-free plasmids were
able to give rise to colonies. In our luciferase reporter sub-
strate, the guanine residues attached to the MMC cross-link
were located within a BspDI restriction sequence. Any muta-
tions at and adjacent to the cross-linked guanine residues
would result in the inactivation of the BspDI site. With primers
flanking the cross-linked site, we used PCR to amplify this
region and examined the resulting fragment by digestion with
BspDI. Ninety-six colonies were analyzed, and 21 were found
to be refractory to BspDI cleavage, which indicated sequence
alterations within the recognition site. Plasmid DNAs were
then isolated from these identified clones, and DNA sequenc-
ing was performed to reveal the nature of each mutation. As
shown in Fig. 6A, all point mutations identified were found to
have occurred at the cytosine position opposing a cross-linked
guanine. Among the base substitutions, 12 were C-to-A trans-
versions, 8 were C-to-T transitions, and 1 was a C-to-G trans-
version. One of the regions with a C-to-T transition also had a
C-to-A transversion 9 bp upstream of the cross-linked guanine
residue. Interestingly, a profound strand bias was observed in
that 19 out of 21 base substitutions were found opposite the
MMC-linked guanine residue in the nontranscribed strand,
indicating that the initial incisions occurred in the transcribed
strand. This result is consistent with our observation that ICL
repair was significantly reduced in TCR mutants. In a parallel
experiment, a promoterless luciferase reporter gene with
FIG. 5. TCR mutants are defective in the repair of the MMC-cross-
linked luciferase reporter. Results show the repair of MMC cross-links
in CSA, complemented CSA (C-CSA), and ERCC6/CSB mutants as
determined by the luciferase reporter assay.
FIG. 6. Mutation spectrum and strand-specific induction of muta-
tions as a result of MMC RIR. Boldface indicates the BspDI recogni-
tion site. (A) In the presence of active transcription through the cross-
linked site, mutations occurred predominantly at the C position in the
transcribed strand, suggesting that the initial NER incisions took place
on the transcribed strand. (B) In the absence of transcription, no
strand bias in mutation induction was observed, as indicated by nearly
equal numbers of mutations on the two strands.
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MMC ICL placed at the same location was used to allow the
repair of the ICLs in vivo and recovered plasmid DNA was
again analyzed for mutations. In all, nine mutations, distrib-
uted evenly between the transcribed and nontranscribed
strands, were identified from 103 colonies (Fig. 6B). This result
indicated that in the absence of transcription through the
cross-linked region, strand-specific mutation formation was
abolished, providing additional support for the idea that TCR
plays an important role in the RIR of MMC ICLs located in
actively transcribed regions.
A parallel mutation analysis was performed to ensure that
the observed mutagenesis at the cross-linked site was a direct
consequence of passage through mammalian cells as opposed
to generation in the repair- and recombination-deficient
AB2480 strain. The cross-linked luciferase substrate was elec-
troporated directly into AB2480 cells. The transformation ef-
ficiency of the MMC cross-linked plasmid was approximately
1.5% of the unmodified luciferase reporter plasmid. PCR am-
plification and analysis of 108 individual colonies revealed that
84 did not contain the cross-linked oligonucleotide and that 24
clones that had the oligonucleotide insert were cleavable by
BspDI. The latter colonies presumably arose from a low level
of contamination of uncross-linked oligonucleotides. These re-
sults indicate that the observed mutations were generated as a
result of repair in the mammalian cells.
We also studied mutation induction in the cross-linked
pCMV-LUC plasmid recovered from XPV cells. Analysis of 75
recovered colonies produced 11 independent clones with mu-
tations around the cross-linked site. The resulting mutation
frequency (15%) may indicate a reduction in the mutation rate
compared to the 22% mutation rate (21 out of 96) for repair-
proficient HT-1080 and AA8 cells. The positions and nature of
base substitutions, primarily A for C and T for C, are similar to
those of XPV-positive repair-proficient cells. These results
suggest that PolH contributes to the ICL-induced mutation but
that other lesion bypass polymerases may have redundant roles
in the RIR mechanism to remove MMC ICLs.
DISCUSSION
We studied the removal of position-defined MMC ICLs in
mammalian cells through a repair-mediated reporter reactiva-
tion assay. Our data suggest that mammalian cells are able to
remove MMC ICLs by an NER-dependent mechanism, which
does not require lesion-free homologous sequences or ele-
ments involved in the recombinational repair of ICLs. The
identification of mutations as a result of this RIR of ICLs
indicates that it is an error-prone pathway that may be, at least
in part, responsible for the observed bifunctional alkylating-
agent-induced mutagenesis.
Model for the RIR of ICLs. The incision step of the NER
pathway consists of a number of essential activities: the exc-
inuclease activities of ERCC1-XPF and XPG, the helicase
activity of TFIIH (XPB and XPD), and the damage-binding
activities of XPA and XPC-human RAD23B. We found that
all five factors were required for the RIR of the MMC ICLs, a
result that is consistent with the results of previous studies of
photoactivated psoralen-mediated ICLs (47). A number of in
vitro studies have suggested the involvement of NER incision
activities in ICL processing. We have shown that the ERCC1-
XPF complex is essential in ICL-induced repair synthesis (26).
Dual incisions 5 to the cross-link were observed and postu-
lated to result in a futile cycle of DNA synthesis (33). Also, the
ERCC1-XPF heterodimer was shown to exhibit an endonucle-
ase activity capable of introducing incisions on the unpaired 3
tail of the cross-link placed in a duplex 4 to 6 bases from a
junction with unpaired DNA (25). These incision reactions,
however, do not lead to the uncoupling of the ICLs, which is a
crucial step in ICL removal. Conversely, if the NER dual
incisions flanked the cross-linked base on the same strand, the
resulting gap structure would effectively provide an uncoupling
mechanism. The observed participation of Pol in the experi-
ments in our study can be best explained by a lesion bypass
gap-filling process, which is substantiated by the identification
of mutations at the site opposing the cross-linked base. These
data, collectively, support a model proposed in Fig. 7. More-
over, ICLs formed with psoralen and MMC differ drastically in
their degrees of helix distortion and their ICL configurations
and have distinct base preferences (13, 35, 48). Hence, the RIR
model may apply to ICLs in general.
Role of TCR in strand-specific formation of mutations. The
TCR pathway repairs lesions located in actively transcribed
regions in the genome more rapidly than those in nontran-
scribed regions. In addition, the transcribed strand is prefer-
entially repaired over the nontranscribed strand (8, 29). In
mammalian cells, two gene products, CSA and CSB, in addi-
tion to the basic NER factors, are essential for TCR function
FIG. 7. Model of lesion bypass mutagenic repair of MMC DNA
interstrand cross-links. The first incision step places two nicks on the
same strand, flanking the cross-linked base. The gap structure is cre-
ated by the unwinding of the incised oligonucleotide and subsequently
filled in by Pol  and other lesion bypass polymerases. Misincorpora-
tion likely occurs when DNA synthesis passes the still cross-linked
base. Subsequently, the remaining lesion is repaired by a second round
of regular NER reaction. Arrows indicate incisions. Diamonds indicate
the positions of potential misincorporations, and dark lines depict
repair synthesis patches.
VOL. 23, 2003 DNA CROSS-LINK REPAIR IN MAMMALIAN CELLS 759
(18, 43). In our study, both the CSA and the CSB mutant were
significantly defective in the repair of MMC ICLs located in
the actively transcribed region of the reporter substrate. These
observations are consistent with the report that TCR is in-
volved in the repair of psoralen cross-links in hamster cells
(20). In our study, a profound strand bias toward the tran-
scribed strand was found, whereas the loss of transcription
completely abolished this effect. Apparently, the TCR pathway
is able to direct the NER incisions toward the transcribed
strand even though two opposing lesions are in virtually the
same location. Our observations provide additional evidence
that the transcription elongation complex may be a strong
determinant of strand-specific repair in the case of ICLs.
TCR is evidently a major contributor in the RIR of MMC
ICLs. Our results with the XP4PA mutant, however, showed
that the repair of the MMC ICLs was also affected in an
XPC-deficient cell line. Additional studies may be required to
understand why the loss of XPC also affects ICL repair in the
XPC mutants, which presumably have an intact TCR function.
Recombination-independent ICL repair is likely a minor
pathway in mammalian cells. Two types of DNA lesions, DSBs
and ICLs, affect both strands of the double helix and can be
repaired through either error-free mechanisms that involve
homologous recombination with undamaged homologous se-
quences as donors or error-prone mechanisms. In the case of
radiation-induced DSBs, the nonhomologous-end-joining
pathway appears to be the predominant mechanism in mam-
mals, as demonstrated by the severe radiation sensitivity of Ku
mutants, while mutants such as XRCC2 and XRCC3 that are
defective in the gene conversion mechanism exhibit minor
sensitivities to ionizing radiation (11). These same XRCC mu-
tants are, nevertheless, extremely sensitive to ICL-inducing
agents, indicating that homologous recombination is likely part
of the major pathway for ICL repair. In mammals, the loss of
NER function results in moderate sensitivity to cross-linking
agents (3, 19). Thus, the NER lesion bypass mechanism does
not seem to be the predominant pathway for ICL removal from
chromosomal DNA in mammalian cells, despite the relatively
high efficiency of ICL repair in our plasmid reporter con-
structs.
A number of factors may limit the participation of the RIR
mechanism. At the site of an ICL, strand separation is severely
restricted by the cross-link, which consequently inhibits the
formation of the bubble structure required for the dual NER
incisions. As a result, the efficiency and accuracy of introducing
flanking incisions may be limited. In budding yeast, the RIR of
psoralen ICLs has recently been characterized (16) and a rev3/
polymerase -dependent repair of nitrogen mustard-mediated
ICLs has been shown to function mostly in stationary-phase
yeast cells (28). Similarly, in mammalian cells, specific stages of
the cell cycle in which ICLs are encountered may further limit
the role of the RIR pathway (15). Although the mechanism for
the RIR of ICLs may not contribute extensively to the overall
removal of ICLs genome-wide, its error-prone nature may be
an important source of induced mutagenesis by cross-linking
agents.
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